Role(s) in Healthcare Innovation:
Concerned Citizen Data Scientist Engineer Patient Activist / Advocate Patient Facilitator / Care Coordinator Programmer Scientist / ResearcherMy Communities
Global Healthcare Innovation AMIA
About Me
Mitch has worked in the financial industry for more than 35 years. He earned a BBA from the University of Wisconsin majoring in finance and economics. Starting as an options market maker in Chicago, he later taught quantitative finance classes at the university level for the trading staff of global banks. Starting in 2000 he had various consulting and management responsibilities for financial industry software vendors Reuters and SunGard (now FIS). Most recently Mitch is using his technology and analytical experience to build Christy Health.
Interested in solutions for:
For myself and those I love For my community For my company I am working on a great new idea for healthcareI am looking for healthcare innovations:
AI in Medicine Connected Health Informatics Managed Care Open Data Patient Power Tools! Wearables Chronic conditions
by
Mitch Stonehocker
Your health data in your hands
by Mitch Stonehocker
You have not backed any projects.
Lets change that!
Discover Projects
No comments on any project yet.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No project reviewed yet.
Lets change that!
Discover Projects
Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.